Times Square Capital Management, LLC Ascendis Pharma A/S Transaction History

Times Square Capital Management, LLC

$6.49 Billion
Q3 2024

A detailed history of Times Square Capital Management, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Times Square Capital Management, LLC holds 500,920 shares of ASND stock, worth $68.3 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

500,920

Previous 596,314 16.0%

Holding current value

$68.3 Million

Previous $81.3 Million 8.01%

% of portfolio

1.15%

Previous 1.3%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$113.0 - $153.43 $10.8 Million - $14.6 Million	-95,394 Reduced 16.0%	500,920 $74.8 Million
Q2 2024 Aug 08, 2024	BUY	$121.07 - $153.67 $2.5 Million - $3.17 Million	20,616 Added 3.58%	596,314 $81.3 Million
Q1 2024 May 07, 2024	SELL	$123.45 - $159.4 $26.8 Million - $34.6 Million	-217,247 Reduced 27.4%	575,698 $87 Million
Q4 2023 Feb 07, 2024	SELL	$86.1 - $127.36 $4.29 Million - $6.35 Million	-49,856 Reduced 5.92%	792,945 $99.9 Million
Q3 2023 Nov 17, 2023	BUY	$86.5 - $103.97 $6.52 Million - $7.84 Million	75,374 Added 9.82%	842,801 $78.9 Million
Q2 2023 Aug 09, 2023	SELL	$69.96 - $97.84 $5.92 Million - $8.28 Million	-84,653 Reduced 9.93%	767,427 $68.5 Million
Q1 2023 May 10, 2023	BUY	$104.9 - $126.78 $6.38 Million - $7.71 Million	60,835 Added 7.69%	852,080 $91.4 Million
Q4 2022 Feb 10, 2023	BUY	$99.42 - $131.97 $15.1 Million - $20 Million	151,570 Added 23.69%	791,245 $96.6 Million
Q3 2022 Nov 09, 2022	BUY	$84.03 - $110.23 $16 Million - $20.9 Million	190,025 Added 42.26%	639,675 $66.1 Million
Q2 2022 Aug 05, 2022	SELL	$78.08 - $117.61 $3.97 Million - $5.97 Million	-50,800 Reduced 10.15%	449,650 $41.8 Million
Q1 2022 May 06, 2022	SELL	$102.18 - $135.75 $4.52 Million - $6.01 Million	-44,250 Reduced 8.12%	500,450 $58.7 Million
Q4 2021 Feb 04, 2022	SELL	$127.1 - $169.66 $5.05 Million - $6.74 Million	-39,700 Reduced 6.79%	544,700 $73.3 Million
Q3 2021 Nov 08, 2021	BUY	$112.67 - $176.92 $24.9 Million - $39.1 Million	221,100 Added 60.86%	584,400 $93.1 Million
Q2 2021 Aug 09, 2021	SELL	$121.62 - $145.29 $12.5 Million - $15 Million	-103,000 Reduced 22.09%	363,300 $47.8 Million
Q1 2021 May 12, 2021	BUY	$124.92 - $173.33 $4.13 Million - $5.74 Million	33,100 Added 7.64%	466,300 $60.1 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $202,607 - $244,898	1,340 Added 0.31%	433,200 $72.2 Million
Q3 2020 Nov 06, 2020	BUY	$134.29 - $154.32 $27.2 Million - $31.2 Million	202,300 Added 88.13%	431,860 $66.6 Million
Q2 2020 Aug 07, 2020	BUY	$110.87 - $156.01 $25.5 Million - $35.8 Million	229,560 New	229,560 $34 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Account

Times Square Capital Management, LLC Ascendis Pharma A/S Transaction History